Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: December 2022

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Anchors Focus and Priority on Berubicin Clinical Development for GBM Treatment

Posted on December 14, 2022 by MissionIR

On September 30, 2022, CNS Pharmaceuticals (NASDAQ: CNSP), a clinical-stage biotechnology company specializing in the development of novel treatments with a focus on brain cancer, Glioblastoma Multiforme (“GBM”), and neuro-oncology, released its financial results for the third quarter of the … Continue reading →

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

Cepton, Inc. (NASDAQ: CPTN) Remains Committed to Improving Road Safety Through Development of Lidar Solutions for Assisted and Autonomous Driving

Posted on December 14, 2022 by MissionIR

Automotive OEMs have made headlines recently for accelerating their commitment to hands-free driving. Ford announced during its third quarter earnings release this year that they intend to focus on developing L2/L3 ADAS capabilities and Honda also announced plans to include … Continue reading →

Posted in Cepton Inc. CPTN | Leave a comment

Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) Offers Solutions for Smart Businesses to Keep Making Cybersecurity a Priority

Posted on December 14, 2022 by MissionIR

In a fragile economy with a possible recession looming on the horizon, savvy companies are taking a close look at ways to tighten their belts. As they do so, a recent Forbes article cautions wise business leaders to keep cybersecurity … Continue reading →

Posted in Cerberus Cyber Sentinel Corp. CISO | Leave a comment

MissionIRNewsBreaks – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Featured in ‘Stock2Me’ Podcast

Posted on December 13, 2022 by MissionIR

BiondVax (NASDAQ: BVXV), a biotechnology company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious and autoimmune diseases, was featured in the latest episode of the Stock2Me Podcast, an IBN solution to provide specialized … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Secures Largest Contract in Its History

Posted on December 13, 2022 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, today announced the largest single contract in the company’s history alongside two new contracts from cities in New York and Georgia. Under the contracts, Knightscope will deploy 12 K5 Autonomous … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Signs RMA as First US Dealer Partner for Commercial EV Lineup

Posted on December 13, 2022 by MissionIR

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced Randy Marion Automotive (“RMA”) as the first dealer group partner for MULN’s commercial EV lineup, which is set to launch in the U.S. in 2023. The commercial EV … Continue reading →

Posted in Mullen Automotive Inc. MULN | Leave a comment

MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Appoints Interim Chief Financial Officer, Changes Auditor

Posted on December 13, 2022 by MissionIR

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, announced that Jonathan Tegge, a member of Brio Financial Group, will shoulder the role of interim CFO effective Dec. 12, 2022. The … Continue reading →

Posted in InMed Pharmaceuticals Inc. INM | Leave a comment

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) 2022 Calendar Year in Review

Posted on December 13, 2022 by MissionIR

In his concluding remarks in this year’s letter to shareholders published January, Lexaria Bioscience (NASDAQ: LEXX) CEO Chris Bunka underlined that “Management of [the company] feels we are on track, on schedule, and on budget to deliver what we hope … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Innovative Inhaled COVID-19 NanoAb Therapy Shows Statistically Significant Efficacy Results in Preclinical Study

Posted on December 13, 2022 by MissionIR

A study recently published in JAMA Network found that nearly 15% of COVID-19 patients admitted to 36 Paris University hospitals had contraindications (excluding factors) to Paxlovid, the leading COVID-19 treatment. While Paxlovid can reduce hospitalization and death among high-risk COVID-19 … Continue reading →

Posted in BiondVax Pharmaceuticals Ltd. BVXV | Leave a comment

MissionIRNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Exclusive Distribution Agreement

Posted on December 12, 2022 by MissionIR

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of gaming platforms, systems and gaming content, has entered into an exclusive distribution agreement with Elray Resources Inc., which trades as Elray Gaming. The agreement gives GMGI exclusive rights to provide … Continue reading →

Posted in Golden Matrix Group Inc. GMGI | Leave a comment